Overview
Vaccinations are crucial for individuals with rheumatic and musculoskeletal diseases (RMDs) due to their increased risk of vaccine-preventable illnesses and potential for severe outcomes 23. Guidelines aim to provide evidence-based recommendations for optimal vaccine use in this population 23.Diagnosis
Management
Special Populations
Key Recommendations
References
1 Price O, Swanton R, Grebely J, Hajarizadeh B, Webb P, Peacock A et al.. Vaccination coverage among people who inject drugs: A systematic review. The International journal on drug policy 2024. link 2 Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC et al.. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis care & research 2023. link 3 Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC et al.. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis & rheumatology (Hoboken, N.J.) 2023. link